Dr Lalchand. Lab

Dr_Lalchand._Lab24 Apr 2024

Healthcare

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Dr Lalchand. Lab

Dr Lalchand. Lab

Healthcare

Dr_Lalchand._Lab24 Apr 2024

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
06-Apr-2024	BC	Resignation of Company Secretary and compliance officer of the Company	06-Apr-2024
01-Dec-2023	BC	Appointment of Mr. Karan Kumar as Company Secretary and Compliance Officer of the Company w.e.f. 01.12.2023	01-Dec-2023
01-Dec-2023	BC	Appointment of Mr. Karan Kumar as Company Secretary and Compliance Officer of the Company w.e.f. 01.12.2023	01-Dec-2023
27-Nov-2023	BC	Resignation of Ms. Monika Joshi as Company and Compliance Officer Revised intimation for Resignation of Ms. Monika Joshi from the position of Company Secretary and Compliance Officer (As per BS	27-Nov-2023
07-Nov-2023	BC	Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve the un-audited Standalone Financial Res	14-Nov-2023

No Rights has been declared by Dr_Lalchand._Lab

Book Closure

Record Date	Split Date	Purpose
06-Apr-2024	-	Resignation of Company Secretary and compliance officer of the Company
01-Dec-2023	-	Appointment of Mr. Karan Kumar as Company Secretary and Compliance Officer of the Company w.e.f. 01.12.2023
01-Dec-2023	-	Appointment of Mr. Karan Kumar as Company Secretary and Compliance Officer of the Company w.e.f. 01.12.2023
27-Nov-2023	-	Resignation of Ms. Monika Joshi as Company and Compliance Officer Revised intimation for Resignation of Ms. Monika Joshi from the position of Company Secretary and Compliance Officer (As per BS
14-Nov-2023	-	Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve the un-audited Standalone Financial Res

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Dr Lalchandani Labs Ltd ₹20.84(0.00/0.00%)	20.84	+0.00	9.03	-22.81	0.00	1.01
Shree Pacetronix Ltd ₹243.60(+11.60/5.00%)	243.60	+11.60	87.68	132.02	22.41	7.74
Kovai Medical Center & Hospital Ltd ₹4,193.40(+41.45/1.00%)	4,193.40	+41.45	4,587.58	111.37	29.01	5.87
Chennai Meenakshi Multispeciality Hospital Ltd ₹37.22(-0.23/-0.61%)	37.22	-0.23	27.80	75.15	103.39	155.94
Fortis Malar Hospitals Ltd ₹82.56(+3.93/5.00%)	82.56	+3.93	154.73	65.95	0.00	2.71
Apollo Hospitals Enterprise Ltd ₹6,258.55(-126.75/-1.99%)	6,258.55	-126.75	89,988.35	41.89	90.12	12.34

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	4.33	4.33	4.33	4.33	4.33	2.93
Reserves Total	4.59	6.15	5.22	4.21	3.73	0.40
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	8.92	10.48	9.55	8.54	8.06	3.33
Secured Loans	1.21	1.43	1.62	0.97	0.00	1.12
Unsecured Loans	5.19	3.72	2.42	0.79	0.90	0.76
Total Debt	6.40	5.15	4.04	1.76	0.90	1.88
Total Liabilities	15.32	15.63	13.59	10.30	8.96	5.21
APPLICATION OF FUNDS :
Gross Block	8.05	7.74	6.65	4.35	3.76	2.19
Less : Accumulated Depreciation	2.65	1.99	1.40	0.88	0.48	0.13
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	5.40	5.75	5.25	3.47	3.28	2.06
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.24	0.24	0.24	0.24	0.24	0.24
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	1.52	1.56	0.68	0.50	0.39	0.27
Sundry Debtors	4.97	4.22	3.98	3.33	1.83	1.14
Cash and Bank	3.10	3.53	2.89	2.25	2.02	0.91
Loans and Advances	1.43	1.50	1.01	1.48	1.60	1.39
Total Current Assets	11.02	10.80	8.56	7.56	5.85	3.71
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	2.23	2.05	1.16	1.40	0.96	0.91
Provisions	0.00	0.29	0.31	0.16	0.16	0.07
Total Current Liabilities	2.23	2.33	1.48	1.55	1.12	0.98
Net Current Assets	8.79	8.47	7.09	6.01	4.72	2.73
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.16	0.16	0.13	0.08	0.05	0.02
Net Deferred Tax	-0.16	-0.16	-0.13	-0.08	-0.05	-0.02
Total Assets	14.26	14.30	12.44	9.64	8.19	5.01
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	3.53	2.89	2.25	2.02	0.91
Net Cash from Operating Activities	0.00	2.01	1.19	-0.10	-0.45
Net Cash Used In Investing Activities	-0.20	-1.53	-2.26	-0.53	-1.95
Net Cash Used In Financing Activities	-0.23	0.16	1.71	0.85	3.51
Net Inc./Dec In Cash And Cash Equivalents	-0.43	0.64	0.64	0.23	1.12
Cash And Cash Equivalents At End Of The Year	3.10	3.53	2.89	2.25	2.02

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

60.78%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

39.22%

**Promoter pledged shareholding 60.78%

About Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Ltd is in the Healthcare sector, having a market capitalization of Rs. 9.03 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes Arjan Lalchandani, Arjan Lalchandani,Mohit Lalchandani,Anchal Gupta,Rajiv Handa,Prakash Jhuraney,Swati Chandra (Dr Lalchandani Labs Ltd) among others.

Chairman

Arjan Lalchandani

Registered office

M-20 Basement,Greater Kailash-1,New Delhi,New Delhi,110048

FAX :

Background

Incorporation Year2017

Face Value₹10

Market Lot4000

How to buy Dr Lalchand. Lab shares on nse?

To buy Dr Lalchand. Lab shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Dr Lalchand. Lab share price today?

The Dr Lalchand. Lab shares price on nse is Rs.20.84 today.

What is the market cap of Dr Lalchand. Lab shares on BSE ?

The company has a market capitalization of Rs.9.03Cr

What is the PE & PB ratio of Dr Lalchand. Lab shares ?

PE is 0 and PB is 1.01

What is the 52 Week High and Low of Dr Lalchand. Lab shares?

Dr Lalchand. Lab stock price high: Rs.35 Dr Lalchand. Lab stock price low: Rs.15.68